Photo taken from: FDA Oncology/X
Mar 24, 2024, 23:14
FDA Oncology: FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues
FDA Oncology recently shared a post on X:
“FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues in this episode of The Uromigos podcast.”
Source: FDA Oncology/X